Lisinopril, one of the most prescribed blood pressure medications in the world, does carry several long-term side effects that range from common annoyances to rare but serious complications. Most people take it for years without major problems, and the cardiovascular benefits of well-controlled blood pressure generally outweigh the risks. But “generally safe” is not the same as “risk-free,” and some of lisinopril’s side effects are specifically tied to prolonged use or can appear suddenly after years of uneventful treatment.
The Persistent Dry Cough
The most recognized long-term side effect of lisinopril is a chronic dry cough. This is not a lisinopril-specific problem but a class-wide issue with all ACE inhibitors, driven by the buildup of bradykinin and other substances in the lungs that the drug prevents from being broken down. The cough is dry, nonproductive, and often worse at night. It can show up weeks or months after starting the medication, or it can develop gradually after a longer period of use. In a study characterizing ACE inhibitor cough, all patients’ coughs resolved once the drug was stopped.
Estimates of how many people develop this cough vary widely, from roughly 5% to over 20% depending on the population studied. Women and people of East Asian descent tend to be affected more often. For many, the cough is mild enough to tolerate. For others, it becomes severe enough to interfere with sleep, trigger vomiting, or lead to other complications.1PubMed. Characterization of cough associated with angiotensin-converting enzyme inhibitors If you have been on lisinopril for months or years and develop a new cough that no one can explain, the medication itself is a likely culprit. Switching to an ARB (a related class of blood pressure drugs that works slightly differently) usually solves the problem.
Angioedema Can Appear After Years of Use
Angioedema is the side effect that keeps pharmacists and emergency physicians on alert. It involves sudden, severe swelling of deeper skin layers, most often in the face, lips, tongue, or throat. When the throat is involved, it can become a medical emergency that threatens the airway. What makes this particularly unsettling as a long-term concern is that it does not always show up early. A large electronic health records study of nearly 135,000 patients prescribed ACE inhibitors found that about 0.7% developed angioedema over five years. The incidence was highest in the first year (about 0.23%) but continued at a steady rate of roughly 0.1% per year for the next four years, meaning the risk never really goes away.2PubMed Central. Epidemiology and Incidence of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record
A case report illustrates the extreme end of this pattern: an elderly woman developed acute throat and tongue swelling after 16 years of uneventful lisinopril use.3PubMed Central. Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema Following Long-Term Lisinopril Use: Response to C1 Esterase Inhibitor Treatment The practical takeaway is that being on lisinopril for a long time without problems does not make you immune. Any new, unexplained swelling of the face, mouth, or throat while taking this drug warrants immediate medical attention, even if you have been on it for a decade.
Potassium Levels and the Need for Ongoing Monitoring
Lisinopril reduces the body’s ability to excrete potassium, which means blood potassium levels can creep upward over time. In most healthy people, the kidneys handle this just fine. But in people with chronic kidney disease, diabetes, heart failure, or those taking other medications that also raise potassium, the risk of hyperkalemia (dangerously high potassium) becomes real. A study of over 5,000 patients with chronic kidney disease who started lisinopril found that about 2.8% developed hyperkalemia within 90 days. Risk factors included older age, reduced kidney function, diabetes, heart failure, use of potassium supplements, and higher lisinopril doses.4PubMed Central. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril
Separate research found that long-acting ACE inhibitors like lisinopril and enalapril were more commonly used among patients who developed hyperkalemia compared with those who did not, and that using these long-acting formulations was independently associated with a higher risk.5JAMA Internal Medicine. Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors: How Much Should We Worry? This is why regular blood work, particularly potassium and kidney function tests, remains important for as long as you take lisinopril. The monitoring is not just a first-few-months precaution; it is a lifelong commitment with this drug.
Kidney Effects Over Time
The relationship between lisinopril and the kidneys is complicated because the drug is often prescribed specifically to protect kidneys in people with diabetes. By lowering pressure within the kidney’s filtering units, it can slow the progression of diabetic kidney disease. A study comparing high-dose and low-dose lisinopril in patients with diabetic nephropathy found that higher doses produced significantly greater reductions in microalbuminuria (a marker of kidney damage) at three months, without meaningful differences in creatinine or potassium levels between the two dose groups.6PubMed Central. Renal Effects of High-Dose Versus Low-Dose Lisinopril in Patients With Diabetic Nephropathy
The flip side is that lisinopril can worsen kidney function in certain situations, particularly when combined with other medications. Research has identified what doctors call the “triple whammy”: combining a diuretic, an NSAID (like ibuprofen or naproxen), and an ACE inhibitor like lisinopril. Each drug on its own has modest kidney effects, but the combination can significantly impair kidney function. Taking two or more of these drug types together was associated with meaningful kidney impairment independent of other diseases.7PubMed Central. Drug combinations and impaired renal function — the ‘triple whammy’ If you take lisinopril long-term and also use a diuretic, be cautious about reaching for over-the-counter NSAIDs for aches and pains.
The Lung Cancer Question
Starting around 2018, several studies raised the question of whether long-term ACE inhibitor use might be associated with a small increase in lung cancer risk. The concern is biologically plausible because ACE inhibitors cause bradykinin and substance P to accumulate, and these molecules can promote cell growth in lung tissue. The evidence, though, is mixed and far from settled.
A nationwide case-control study found that high cumulative doses of ACE inhibitors were associated with about a 33% increase in lung cancer risk, but lower cumulative doses showed no meaningful association.8PubMed. Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer: A Nationwide Nested Case-Control Study A systematic review and meta-analysis pooling multiple studies found a similar pattern: ACE inhibitor use overall was linked to about a 19% higher lung cancer risk, but only in studies with a mean follow-up period longer than five years. Shorter follow-up periods showed much smaller associations.9British Journal of Cancer. Association between angiotensin-converting enzyme inhibitors and the risk of lung cancer: a systematic review and meta-analysis
Before you panic, some context: the absolute risk increase, if real, is small. Observational studies like these cannot prove causation, and residual confounding (particularly from smoking, which is both a risk factor for high blood pressure and the dominant cause of lung cancer) is hard to completely rule out. Regulatory agencies have not issued warnings or recommended switching away from ACE inhibitors based on this evidence. Still, if you have been on lisinopril for many years and have additional lung cancer risk factors, it is a reasonable thing to discuss with your doctor.
Cognitive Effects in Older Adults
An emerging area of research involves how different blood pressure medications affect brain function over time. Lisinopril does not cross the blood-brain barrier as readily as some other ACE inhibitors, and there is debate about whether this matters for cognitive outcomes. A small study found that lisinopril blood levels showed a negative correlation with perceptual motor skills, complex attention, and learning, suggesting a potential cognitive downside that is not yet well understood.10PubMed Central. The Correlation between Two Angiotensin-Converting Enzyme Inhibitor’s Concentrations and Cognition
A randomized trial comparing lisinopril to candesartan (an ARB) in older adults with mild cognitive impairment found that after 12 months, the candesartan group showed improved executive function while the lisinopril group showed decline. The candesartan group also performed better on memory tasks. These differences held even after adjusting for blood pressure levels, suggesting the effect was not simply about how well blood pressure was controlled.11JAMA Network Open. Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial This was a single trial with a specific population (older adults who already had mild cognitive impairment), so it would be premature to generalize from it. But for older adults who notice cognitive changes while on long-term lisinopril, the choice of antihypertensive agent is worth revisiting with their physician.
Liver Injury Is Rare but Real
Lisinopril-induced liver damage is uncommon enough that only a handful of cases have been published in the medical literature. A review identified just seven reported cases of lisinopril-induced liver injury, with most involving direct damage to liver cells and a couple involving a cholestatic pattern where bile flow is blocked.12PubMed Central. Lisinopril-Induced Liver Injury: An Unusual Presentation and Literature Review One reported case involved a patient who developed cholestatic hepatitis two full years after starting lisinopril, consistent with the long latency period seen in other cases.13British Journal of Medical Practitioners. Cholestatic hepatitis: An unusual presentation of lisinopril induced hepatotoxicity
The rarity of this side effect means it should not discourage anyone from taking the medication. But the long latency is the clinically relevant detail: if you develop unexplained jaundice, dark urine, or elevated liver enzymes after months or years on lisinopril, the drug should be considered as a possible cause even though it has been well tolerated up to that point.
Pregnancy and Reproductive Safety
Lisinopril is strictly contraindicated in pregnancy, and this applies across all trimesters. Exposure to ACE inhibitors during pregnancy has been associated with serious harm to the developing fetus. A large cohort study found that infants exposed to ACE inhibitors during even the first trimester alone had a nearly threefold increased risk of major birth defects compared with unexposed infants. The risks were particularly elevated for malformations of the cardiovascular system and the central nervous system.14PubMed. Major congenital malformations after first-trimester exposure to ACE inhibitors
Later in pregnancy, the picture is even more concerning. ACE inhibitors can cause fetal kidney dysfunction through reduced blood flow and decreased filtration. A review of published cases found that six out of 14 neonates who developed kidney failure after maternal ACE inhibitor therapy died.15PubMed. Fetal exposure to lisinopril: neonatal manifestations and management Women of childbearing age who take lisinopril need a reliable plan for switching to a pregnancy-safe blood pressure medication before conception, and anyone who becomes pregnant while on lisinopril should contact their doctor immediately.
Falls and Blood Pressure Stability in Older Adults
A common worry about long-term blood pressure medication is that it might cause dizziness, fainting, or falls, particularly as people age. The ALLHAT trial, one of the largest antihypertensive studies ever conducted, addressed this directly. Over nearly five years of follow-up in older adults, lisinopril showed no increased risk of falls, fainting, or orthostatic hypotension compared with a diuretic or a calcium channel blocker. In fact, the fall rate with lisinopril was among the lowest of the three drugs studied.16PubMed Central. The Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: the ALLHAT Trial This is reassuring for older adults on long-term therapy, though individual responses vary and anyone experiencing persistent dizziness should have it evaluated.
Metabolic Neutrality
Some blood pressure medications can worsen blood sugar control or disrupt cholesterol levels over time, which matters when many people with hypertension also have or are at risk for diabetes. The evidence on lisinopril is generally favorable here. A controlled study found that lisinopril did not produce significant changes in fasting blood sugar, insulin levels, or cholesterol and lipid fractions in people with hypertension.17PubMed. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients Some research has even suggested lisinopril may modestly improve insulin sensitivity compared with certain other blood pressure drugs, though the clinical significance of that difference remains debated.18PubMed Central. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients In practical terms, lisinopril is considered metabolically neutral to slightly beneficial, which is part of why it remains a first-line choice for patients with both hypertension and diabetes.
A Rare Blood Disorder
One unusual case report documented a patient who developed unexplained chronic inflammation and anemia while on lisinopril. After extensive investigation ruled out other causes, the anemia was attributed to the drug and resolved after discontinuation.19PubMed Central. An unusual cause of anaemia of chronic disease: lisinopril-induced chronic inflammatory state This kind of side effect is extraordinarily rare, but it is worth mentioning because anemia that develops insidiously in someone on long-term lisinopril could go undiagnosed for a long time if the drug is not considered as a possible trigger. If routine blood work shows declining red blood cell counts without an obvious explanation, lisinopril is at least worth mentioning to whoever is working up the cause.
What Ongoing Monitoring Looks Like
If you are on lisinopril for the long haul, the practical question becomes what to watch for and how often. Most guidelines recommend checking kidney function and potassium levels within a couple of weeks of starting the drug or changing the dose, then periodically afterward. “Periodically” usually means at least once or twice a year for stable patients, and more often if you have kidney disease, diabetes, or take other medications that affect potassium. Beyond lab work, self-monitoring for new symptoms is important: a new cough, any facial or throat swelling, unexplained fatigue, or yellowing of the skin or eyes all warrant a conversation with your prescriber. The drug’s long latency for rare side effects like angioedema and liver injury means you cannot let your guard down entirely just because the first year went smoothly.
The broader picture with lisinopril is that it is a well-studied, effective medication that millions of people take safely for decades. Its long-term side effect profile is not a reason to avoid it when it is otherwise a good fit. But it is a reason to stay engaged with regular check-ups and blood work rather than putting the prescription on autopilot.